Fingerprint
Dive into the research topics of 'A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically